DIN 02472309 — JAMP DICLOFENAC TOPICAL SOLUTION 1.5 %
JAMP DICLOFENAC TOPICAL SOLUTION is a solution of Diclofenac potassium marketed by JAMP PHARMA CORPORATION. The full Diclofenac potassium monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02472309
- Brand name
- JAMP DICLOFENAC TOPICAL SOLUTION
- Active ingredient
- Diclofenac potassium
- Strength
- 1.5 %
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Nonsteroidal anti-inflammatory drug (NSAID) - acetic acid derivative
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Diclofenac potassium products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00839175 | APO-DICLO | 25 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED |
| 00839183 | APO-DICLO | 50 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED |
| 02091194 | APO-DICLO SR | 100 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02162814 | APO-DICLO SR | 75 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02441020 | APO-DICLOFENAC OPHTHALMIC | 0.1 % | SOLUTION | APOTEX INC | DORMANT |
| 02381680 | CAMBIA | 50 MG | POWDER FOR SOLUTION | ARALEZ PHARMACEUTICALS CANADA INC | MARKETED |
| 02475065 | DICLOFENAC | 0.1 % | SOLUTION | PHARMA STULLN INC. | MARKETED |
| 02476134 | DICLOFENAC SODIUM SOLUTION | 1.5 % | SOLUTION | HIKMA CANADA LIMITED | DORMANT |
| 02434571 | DICLOFENAC TOPICAL SOLUTION | 1.5 % | SOLUTION | STERIMAX INC | DORMANT |
| 02534525 | JAMP DICLOFENAC | 0.1 % | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02563290 | JAMP DICLOFENAC FOR SOLUTION | 50 MG | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02247265 | PENNSAID | 1.5 % | SOLUTION | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02356783 | PMS-DICLOFENAC | 1.5 % | SOLUTION | PHARMASCIENCE INC | DORMANT |
| 02302616 | PMS-DICLOFENAC | 25 MG | TABLET (DELAYED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02302624 | PMS-DICLOFENAC | 50 MG | TABLET (DELAYED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 00870978 | PRO-DICLOFENAC | 50 MG | TABLET (DELAYED-RELEASE) | PRO DOC LIMITEE | MARKETED |
| 02560631 | RIVA-DICLOFENAC | 50 MG | POWDER FOR SOLUTION | LABORATOIRE RIVA INC. | MARKETED |
| 02261774 | SANDOZ DICLOFENAC RAPIDE | 50 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02261928 | SANDOZ-DICLOFENAC | 50 MG | SUPPOSITORY | SANDOZ CANADA INCORPORATED | MARKETED |
| 02420988 | TARO-DICLOFENAC | 1.5 % | SOLUTION | TARO PHARMACEUTICALS INC | MARKETED |
| 02564475 | TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION | 50 MG | POWDER FOR SOLUTION | TARO PHARMACEUTICALS INC | MARKETED |
| 00808547 | TEVA-DICLOFENAC EC | 50 MG | TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | MARKETED |
| 02048698 | TEVA-DICLOFENAC SR | 100 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | DORMANT |
| 02158582 | TEVA-DICLOFENAC SR | 75 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02239355 | TEVA-DICLOFENAC-K | 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 00632724 | VOLTAREN | 50 MG | SUPPOSITORY | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 00881635 | VOLTAREN RAPIDE | 50 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |